Baird Maintains Neutral on HCA Healthcare, Raises Price Target to $409
Benzinga Newsdesk 4 days ago
Analyst RatingsNewsPrice TargetHot
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $393 to $409.
Baird analyst Michael Ha maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $393 to $409.